G Dranitsaris: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Bisphosphonate use for metastatic breast cancer –too much? too little? too late to start again?

M. Vanhuyse, M.C. Gainford, W. Ooi, G. Dranitsaris, M. Clemons

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

52

A phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases despite standard bisphosphonate (BP) therapy

M. Clemons, G. Dranitsaris, W.S. Ooi, D.E.C. Cole

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

53

P64. Skeletal related events (SREs) in patients with bone metastases from breast cancer treated with intravenous (i.v.) bisphosphonates (BPs) in the non-trial setting

Mateya Trinkaus, Christine Simmons, Jeffrey Myers, George Dranitsaris, Mark Clemons

Journal:

Cancer Treatment Reviews

Year:

2008

Language:

english

File:

PDF, 29 KB

english, 2008

54

3603 POSTER The Number Needed to Treat (NNT) as a Measure of Incremental Drug Benefit: Denosumab Vs. Zoledronic Acid for the Prevention of Skeletal Related Events (SREs) in Patients With Other Solid Tumours or Multiple Myeloma

G. Dranitsaris, S. Kaura

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 57 KB

english, 2011

55

3602 POSTER The Number Needed to Treat (NNT) as a Measure of Incremental Drug Benefit: Denosumab Vs. Zoledronic Acid for the Prevention of Skeletal Related Events (SREs) in Castration-Resistant Prostate Cancer (CRPC)

G. Dranitsaris, S. Kaura

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 39 KB

english, 2011

56

Chemotherapy-induced anaemia during adjuvant treatment for breast cancer: development of a prediction model

George Dranitsaris, Mark Clemons, Sunil Verma, Cathy Lau, Mark Vincent

Journal:

The Lancet Oncology

Year:

2005

Language:

english

File:

PDF, 243 KB

english, 2005

57

The price function of toxicity

Mark D Vincent, George Dranitsaris

Journal:

The Lancet Oncology

Year:

2009

Language:

english

File:

PDF, 212 KB

english, 2009

58

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

Simmons, C., Miller, N., Geddie, W., Gianfelice, D., Oldfield, M., Dranitsaris, G., Clemons, M. J.

Journal:

Annals of Oncology

Year:

2009

Language:

english

File:

PDF, 122 KB

english, 2009

59

Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer

Amir, E., Miller, N., Geddie, W., Freedman, O., Kassam, F., Simmons, C., Oldfield, M., Dranitsaris, G., Tomlinson, G., Laupacis, A., Tannock, I. F., Clemons, M.

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 153 KB

english, 2012

60

Clinical trial design in biosimilar drug development

Dranitsaris, G., Dorward, K., Hatzimichael, E., Amir, E.

Journal:

Investigational New Drugs

Year:

2013

Language:

english

File:

PDF, 392 KB

english, 2013

61

O-193 The impact of practice guidelines and funding policies on the utilization and cost of chemotherapy in advanced non-small cell lung cancer (NSCLC): The experience from the province of Ontario, Canada

Evans, William K., Dranitsaris, George, Milliken, Debbie, Zanke, Brent

Journal:

Year:

2003

Language:

english

File:

PDF, 166 KB

english, 2003

62

PCN56 NAB-PACLITAXEL OR DOCETAXEL; AS ALTERNATIVES TO CONVENTIONAL PACLITAXEL FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC): A COST UTILITY ANALYSIS IN FIVE EUROPEAN COUNTRIES

G Dranitsaris, M Lidgren, J Lundkvist, R Coleman

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 65 KB

english, 2008

63

PRS39 THE IMPACT OF FORMULARY POLICIES ON THE USE OF MEDICATION FOR RESPIRATORY DISEASE: A COMPARISON OF DRUG UTILIZATION IN THE PROVINCES OF ONTARIO AND ALBERTA

J Pilla, L Dunn, G Dranitsaris

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 68 KB

english, 2008

64

PCN21 NUMBER NEEDED TO TREAT (NNT) ANALYSIS COMPARING BENEFITS OF LETROZOLE WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH NODE-POSITIVE BREAST CANCER

N Dhillon, S Kaura, G Dranitsaris, H Rugo

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 80 KB

english, 2009

65

PR1 THE APPLICATION OF PHARMACOECONOMIC MODELING TO ESTIMATE A VALUE-BASED PRICE FOR NEW CANCER DRUGS IN A PUBLICLY FUNDED HEALTH-CARE SYSTEM

G Dranitsaris, I Truter, M Lubbe, B Spirovski, W Cottrell, J Edwards

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 77 KB

english, 2010

66

PCN140 IMPROVING PATIENT ACCESS TO CANCER DRUGS IN INDIA: USING ECONOMIC MODELING TO ESTIMATE A DRUG COST BASED ON MEASURES OF SOCIETAL VALUE

G Dranitsaris, I Truter, M Lubbe, N Sriramanakoppa, V Mendonca, S Mahagaonkar

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 75 KB

english, 2010

67

PCV13 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS (VTES) IN TOTAL HIP REPLACEMENT (THR) SURGERY

G Dranitsaris, V Jelincic, Y Choe

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 75 KB

english, 2010

68

2116 POSTER Nab-Paclitaxel weekly or Q3Wks compared to Docetaxel Q3Wks as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial

G. Dranitsaris, R. Coleman, W.J. Gradishar

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 58 KB

english, 2007

69

Are Estring® and Vagifem® Equally Effective and Safe for the Treatment of Urogenital Atrophy in Breast Cancer Patients on Aromatase Inhibitor Therapy?

C.E. Simmons, I. Kuchuk, O.C. Freedman, T. Colgan, A. Dodd, K. Kulhanek, J. Sheiner, G. Dranitsaris, M. Dowsett, E. Folkerd, M.J. Clemons

Journal:

Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 116 KB

english, 2012

70

PCV22 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN IN PATIENTS WITH UNSTABLE CORONARY ARTERY DISEASE

G. Dranitsaris, V. Jelincic, Y. Choe

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 57 KB

english, 2011

71

PCN71 USING MEASURES OF SOCIETAL VALUE AND ECONOMIC MODELING TO ESTIMATE PRICES FOR CANCER DRUGS IN SOUTH AFRICA

G. Dranitsaris, I. Truter, M. Lubbe, S. Fourie

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 56 KB

english, 2011

72

PCN78 THE DEVELOPMENT OF A VALUE BASED PRICING INDEX FOR NEW DRUGS IN METASTATIC COLORECTAL CANCER

G. Dranitsaris, I. Truter, M. Lubbe

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

73

PCN70 USING PHARMACOECONOMIC MODELING TO DETERMINE A VALUE-BASED PRICE OF NEW CANCER DRUGS IN MALAYSIA

G. Dranitsaris, I. Truter, M. Lubbe, S. Mahagaonkar

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 56 KB

english, 2011

74

PNP20: COST UTILITY ANALYSIS OF IMMUNOGLOBULINS (IVIG) VERSUS PLASMA EXCHANGE (PE) FOR THE TREATMENT OF GUILLAIN BARRE SYNDROME (GBS)

F Jivraj, G Dranitsaris, M Nicolle

Journal:

Value in Health

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

75

Nab-paclitaxel or docetaxel; as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): cost utility analysis from the perspective of the United Kingdom (UK)

G. Dranitsaris, M. Lidgren, J. Lundkvist, R. Coleman

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 60 KB

english, 2008

76

Letrozole or anastrozole for the prevention of early recurrences in post menopausal women with early stage breast cancer: using number needed to treat (NNT) to compare benefit

H. Ruqo, M. Rourke, G. Dranitsaris, S. Kaura

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 59 KB

english, 2008

77

How much benefit is needed to continue aromatase inhibitors (Als) beyond 5 years – A patient and physician survey

S. Gandhi, K. Towns, S. Allegro, N. Merchant, R. Tseng, G. Dranitsaris, T. Petrella, R. Dent, S. Verma

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

78

5027 A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and non-steroidal (anastrozole) aromatase inhibitors on biomarkers in post-menopausal women with hormone receptor positive locally advanced breast cancer (LABC)

O. Freedman, E. Amir, G. Dranitsaris, M. Dowsett, D.E.C. Cole, W. Hanna, F. O'Malley, E. Folkerd, S. Verma, M.J. Clemons

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

79

5066 Nab-paclitaxel weekly or Q3w compared to docetaxel Q3w as first-line therapy in patients with metastatic breast cancer (MBC): an economic analysis of a prospective randomized trial from the perspective of the German health care system

G. Dranitsaris, T. Schöning

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 50 KB

english, 2009

80

Severe Diarrhea in Patients with Advanced- Stage Colorectal Cancer Receiving FOLFOX or FOLFIRI Chemotherapy: The Development of a Risk Prediction Tool

George Dranitsaris, Amil Shah, Biljana Spirovski, Mark Vincent

Journal:

Clinical Colorectal Cancer

Year:

2007

Language:

english

File:

PDF, 179 KB

english, 2007

81

von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease

Hatzimichael, Eleftheria, Dranitsaris, George, Dasoula, Aggeliki, Benetatos, Leonidas, Stebbing, Justin, Crook, Tim, Bourantas, Konstantinos L.

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 155 KB

english, 2009

82

Eltrombopag or Intravenous Immunoglobulin as a Bridge to Splenectomy in Adults With Chronic Idiopathic Thrombocytopenic Purpura: A Canadian Economic Analysis

George Dranitsaris, Peter Tsang

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

83

Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature

Dranitsaris, George, Johnston, Mary, Poirier, Susan, Schueller, Trudi, Milliken, Debbie, Green, Esther, Zanke, Brent

Journal:

Journal of Oncology Pharmacy Practice

Year:

2005

Language:

english

File:

PDF, 145 KB

english, 2005

84

A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer

OC Freedman, E Amir, G Dranitsaris, M Dowsett, DEC Cole, H Kahn…

Journal:

Breast Cancer Research

Year:

2009

Language:

english

File:

PDF, 461 KB

english, 2009

85

Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia

James A. Chiarotto, George Dranitsaris

Journal:

Supportive Care in Cancer

Year:

2013

Language:

english

File:

PDF, 154 KB

english, 2013

86

Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients

Dranitsaris, George, Vincent, Mark, Crowther, Mark

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 132 KB

english, 2006

87

Study of specific genetic and epigenetic variables in multiple myeloma

Hatzimichael, Eleftheria, Dasoula, Aggeliki, Benetatos, Leonidas, Syed, Nelofer, Dranitsaris, George, Crook, Tim, Bourantas, Konstantinos

Journal:

Leukemia and Lymphoma

Year:

2010

Language:

english

File:

PDF, 194 KB

english, 2010

88

Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy

Dranitsaris, George, Schmitz, Susanne, Broom, Reuben J.

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 325 KB

english, 2013

89

Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time?

Dranitsaris, George, Clemons, Mark

Journal:

Supportive Care in Cancer

Year:

2014

Language:

english

File:

PDF, 76 KB

english, 2014

90

Preference weights for chemotherapy side effects from the perspective of women with breast cancer

Kuchuk, I., Bouganim, N., Beusterien, K., Grinspan, J., Vandermeer, L., Gertler, S., Dent, S. F., Song, X., Segal, R., Mazzarello, S., Crawley, F., Dranitsaris, G., Clemons, M.

Journal:

Breast Cancer Research and Treatment

Year:

2013

Language:

english

File:

PDF, 366 KB

english, 2013

91

Evaluating the Impact of Bevacizumab Maintenance Therapy on Overall Survival in Advanced Non–Small-Cell Lung Cancer

Dranitsaris, George, Beegle, Nancy, Ravelo, Arliene, Kalberer, Traci, Yu, Elaine, Thomas, Sachdev

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 430 KB

english, 2013

92

A Prospective Time and Motion Analysis Comparing Intravenous (IV) Vesus Subcutaneous (SC) Bortezomib in Patients with Multiple Myeloma (MM)

Dranitsaris, G., Kaura, S.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 58 KB

english, 2013

93

PCN50 A Pilot Assessment to Determine Cost of Apheresis Treatment

Rebeira, M., Dranitsaris, G.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

94

Urinary N-Telopeptide Is a Rapid Predictor of Response to and Palliative Benefit from Bisphosphonate Therapy in Patients with Metastatic Breast Cancer

Simmons, Christine, Broom, Reuben J., Cole, David E.C., Dranitsaris, George, Clemons, Mark

Journal:

Supportive Cancer Therapy

Year:

2007

Language:

english

File:

PDF, 418 KB

english, 2007

95

PCN83 Novel Targeted Drug Therapies in the Cancer Setting: A Descriptive Comparison of Efficacy and Cost

Dranitsaris, G., Kaura, S.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

96

PSY31 POSACONAZOLE VS. FLUCONAZOLE OR ITRACONAZOLE FOR THE PREVENTION OF FUNGAL INFECTIONS IN CANCER PATIENTS WITH PROLONGED NEUTROPENIA: A COST-EFFECTIVENESS ANALYSIS

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 79 KB

english, 2010

97

PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Comparative Effectiveness Analysis Using Indirect Statistical Techniques

Kaura, S., Dranitsaris, G.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

98

PCN92 The Lifecycle Value of Oncology Medicines

Kim, T., Dranitsaris, G.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

99

Small Molecule Targeted Therapies for the Second Line Treatment of Metastatic Renal Cell Carcinoma (mRCC): A Systematic Review and Indirect Comparison of Safety and Efficacy

Dranitsaris, G., Schmitz, S., Broom, R.J.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 60 KB

english, 2013

100

MOTHS AS PESTS IN THE PHARMACY.

Dranitsaris, G., Schmitz, S., Broom, R.J.

Journal:

Year:

1921

Language:

english

File:

PDF, 416 KB

english, 1921